Aragen is a leading provider of outsourced discovery, development, and manufacturing services across both large and small molecule platform...

Investor will buy out ChrysCapital stake; co-promoters looking to monetise holding

Quadria and Europe-based co-investors DEG and Swedfund are in the process of hiring an investment banker to shepherd the process.

Private equity firm Quadria Capital has concluded a Rs 475.31 crore investment in biopharmaceutical active ingredient manufacturer Concord ...

The total deal value was driven by one big-ticket transaction, which almost matches the total value of the balance 33 deals.